

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | diol metabolic process (GO:0034311) | 9.88929076 |
| 2 | regulation of translational termination (GO:0006449) | 9.64003043 |
| 3 | behavioral response to ethanol (GO:0048149) | 9.52293956 |
| 4 | sphingoid metabolic process (GO:0046519) | 9.09801986 |
| 5 | regulation of chronic inflammatory response (GO:0002676) | 8.98033211 |
| 6 | ether lipid metabolic process (GO:0046485) | 8.97679729 |
| 7 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 8.85598848 |
| 8 | regulation of protein glycosylation (GO:0060049) | 8.78348070 |
| 9 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 8.60446445 |
| 10 | single fertilization (GO:0007338) | 8.51440631 |
| 11 | adult feeding behavior (GO:0008343) | 8.47450993 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 8.43978719 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 8.43978719 |
| 14 | tryptophan catabolic process (GO:0006569) | 8.43978719 |
| 15 | heterotypic cell-cell adhesion (GO:0034113) | 8.40243595 |
| 16 | piRNA metabolic process (GO:0034587) | 7.69225664 |
| 17 | positive regulation of type 2 immune response (GO:0002830) | 7.45858467 |
| 18 | negative regulation of interleukin-10 production (GO:0032693) | 7.26791074 |
| 19 | tryptophan metabolic process (GO:0006568) | 7.24809576 |
| 20 | regulation of acrosome reaction (GO:0060046) | 7.16395864 |
| 21 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 7.15519058 |
| 22 | notochord development (GO:0030903) | 6.91155323 |
| 23 | positive regulation of cAMP-mediated signaling (GO:0043950) | 6.74983721 |
| 24 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 6.32777992 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 5.76867458 |
| 26 | fertilization (GO:0009566) | 5.60084618 |
| 27 | thrombin receptor signaling pathway (GO:0070493) | 5.46943674 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.44787293 |
| 29 | cellular biogenic amine catabolic process (GO:0042402) | 5.42511236 |
| 30 | amine catabolic process (GO:0009310) | 5.42511236 |
| 31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.33498049 |
| 32 | indolalkylamine metabolic process (GO:0006586) | 5.30721092 |
| 33 | negative regulation of glycoprotein metabolic process (GO:1903019) | 5.26178015 |
| 34 | negative regulation of interleukin-8 production (GO:0032717) | 5.11212738 |
| 35 | glycerol ether metabolic process (GO:0006662) | 4.90239266 |
| 36 | benzene-containing compound metabolic process (GO:0042537) | 4.84939628 |
| 37 | cellular response to ammonium ion (GO:0071242) | 4.72584707 |
| 38 | ether metabolic process (GO:0018904) | 4.68617181 |
| 39 | digestion (GO:0007586) | 4.56123867 |
| 40 | negative regulation of endopeptidase activity (GO:0010951) | 4.50859769 |
| 41 | ncRNA catabolic process (GO:0034661) | 4.46972035 |
| 42 | negative regulation of T cell apoptotic process (GO:0070233) | 4.39924789 |
| 43 | epithelial cell morphogenesis (GO:0003382) | 4.33670884 |
| 44 | negative regulation of cell-matrix adhesion (GO:0001953) | 4.32719677 |
| 45 | signal complex assembly (GO:0007172) | 4.31718537 |
| 46 | negative regulation of peptidase activity (GO:0010466) | 4.31088721 |
| 47 | regulation of cAMP-mediated signaling (GO:0043949) | 4.30984773 |
| 48 | positive regulation of cell-cell adhesion (GO:0022409) | 4.22612844 |
| 49 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.20064043 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.18933583 |
| 51 | regulation of female receptivity (GO:0045924) | 4.10869824 |
| 52 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.06697635 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.06697635 |
| 54 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.98957267 |
| 55 | cellular response to alkaloid (GO:0071312) | 3.97071101 |
| 56 | protein-chromophore linkage (GO:0018298) | 3.89581671 |
| 57 | regulation of type 2 immune response (GO:0002828) | 3.88240047 |
| 58 | transepithelial transport (GO:0070633) | 3.87959126 |
| 59 | negative regulation of cyclase activity (GO:0031280) | 3.79180802 |
| 60 | tachykinin receptor signaling pathway (GO:0007217) | 3.79100473 |
| 61 | indole-containing compound metabolic process (GO:0042430) | 3.78447973 |
| 62 | vitamin catabolic process (GO:0009111) | 3.77048739 |
| 63 | fat-soluble vitamin catabolic process (GO:0042363) | 3.77048739 |
| 64 | pyrimidine dimer repair (GO:0006290) | 3.76386797 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 3.71928568 |
| 66 | regulation of odontogenesis (GO:0042481) | 3.70219622 |
| 67 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.67768198 |
| 68 | cornea development in camera-type eye (GO:0061303) | 3.66039508 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.65060425 |
| 70 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.64737616 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.62034098 |
| 72 | mRNA cleavage (GO:0006379) | 3.61907408 |
| 73 | negative regulation of lyase activity (GO:0051350) | 3.57352105 |
| 74 | defense response to bacterium (GO:0042742) | 3.56382183 |
| 75 | glomerular visceral epithelial cell development (GO:0072015) | 3.55672038 |
| 76 | female mating behavior (GO:0060180) | 3.51887559 |
| 77 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.50447960 |
| 78 | DNA methylation involved in gamete generation (GO:0043046) | 3.48479917 |
| 79 | negative regulation of protein autophosphorylation (GO:0031953) | 3.44040319 |
| 80 | neuronal action potential (GO:0019228) | 3.38188912 |
| 81 | cell-cell junction maintenance (GO:0045217) | 3.35346725 |
| 82 | N-acetylneuraminate metabolic process (GO:0006054) | 3.34892627 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33434828 |
| 84 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.33309587 |
| 85 | coenzyme catabolic process (GO:0009109) | 3.32174711 |
| 86 | spermatid development (GO:0007286) | 3.28864846 |
| 87 | protein localization to synapse (GO:0035418) | 3.28754631 |
| 88 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.25281695 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.23763074 |
| 90 | regulation of meiosis I (GO:0060631) | 3.23359446 |
| 91 | rhodopsin mediated signaling pathway (GO:0016056) | 3.22980925 |
| 92 | regulation of translational elongation (GO:0006448) | 3.20326557 |
| 93 | alpha-linolenic acid metabolic process (GO:0036109) | 3.19569446 |
| 94 | response to morphine (GO:0043278) | 3.19562765 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14646387 |
| 96 | ribonucleoprotein complex disassembly (GO:0032988) | 3.12528734 |
| 97 | glycosphingolipid metabolic process (GO:0006687) | 3.11979558 |
| 98 | left/right axis specification (GO:0070986) | 3.11818723 |
| 99 | glomerular epithelial cell development (GO:0072310) | 3.09481046 |
| 100 | response to bacterium (GO:0009617) | 3.07719277 |
| 101 | dopamine receptor signaling pathway (GO:0007212) | 3.07276407 |
| 102 | response to isoquinoline alkaloid (GO:0014072) | 3.05807024 |
| 103 | regulation of lipoprotein metabolic process (GO:0050746) | 3.03094868 |
| 104 | polyol biosynthetic process (GO:0046173) | 3.03017157 |
| 105 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.02629027 |
| 106 | seminiferous tubule development (GO:0072520) | 24.7639204 |
| 107 | omega-hydroxylase P450 pathway (GO:0097267) | 2.98246923 |
| 108 | negative regulation of exocytosis (GO:0045920) | 2.96544220 |
| 109 | sensory perception of pain (GO:0019233) | 2.96335934 |
| 110 | N-terminal protein amino acid acetylation (GO:0006474) | 2.94963396 |
| 111 | regulation of macrophage activation (GO:0043030) | 2.94435702 |
| 112 | complement activation, alternative pathway (GO:0006957) | 2.94387574 |
| 113 | negative regulation of proteolysis (GO:0045861) | 2.92436475 |
| 114 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.92277856 |
| 115 | thyroid hormone generation (GO:0006590) | 2.88913102 |
| 116 | synaptic transmission, glutamatergic (GO:0035249) | 2.88621426 |
| 117 | glomerular basement membrane development (GO:0032836) | 2.83097192 |
| 118 | positive regulation of fatty acid transport (GO:2000193) | 2.82047359 |
| 119 | negative regulation of protein maturation (GO:1903318) | 2.81791757 |
| 120 | negative regulation of protein processing (GO:0010955) | 2.81791757 |
| 121 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.80779239 |
| 122 | membrane lipid metabolic process (GO:0006643) | 2.79714338 |
| 123 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.78289373 |
| 124 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.77691207 |
| 125 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.76683259 |
| 126 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.76166513 |
| 127 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75449571 |
| 128 | glycerophospholipid catabolic process (GO:0046475) | 2.74386747 |
| 129 | positive regulation of icosanoid secretion (GO:0032305) | 2.74067632 |
| 130 | cysteine metabolic process (GO:0006534) | 2.73452704 |
| 131 | glial cell proliferation (GO:0014009) | 2.73366719 |
| 132 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.72909264 |
| 133 | O-glycan processing (GO:0016266) | 2.72457882 |
| 134 | lipopolysaccharide metabolic process (GO:0008653) | 2.71091588 |
| 135 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.70847830 |
| 136 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.68516124 |
| 137 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.68516124 |
| 138 | thyroid hormone metabolic process (GO:0042403) | 2.67570677 |
| 139 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.67520709 |
| 140 | sialylation (GO:0097503) | 2.67357091 |
| 141 | smooth muscle tissue development (GO:0048745) | 2.66556826 |
| 142 | glycolipid metabolic process (GO:0006664) | 2.66379804 |
| 143 | regulation of activated T cell proliferation (GO:0046006) | 2.65428195 |
| 144 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.64723858 |
| 145 | high-density lipoprotein particle remodeling (GO:0034375) | 2.64636929 |
| 146 | regulation of glycoprotein biosynthetic process (GO:0010559) | 2.64045765 |
| 147 | regulation of beta-amyloid formation (GO:1902003) | 2.63900451 |
| 148 | response to caffeine (GO:0031000) | 2.63731881 |
| 149 | urate metabolic process (GO:0046415) | 2.62517975 |
| 150 | negative regulation of hydrolase activity (GO:0051346) | 2.59899421 |
| 151 | regulation of memory T cell differentiation (GO:0043380) | 2.59235097 |
| 152 | low-density lipoprotein particle clearance (GO:0034383) | 2.55075508 |
| 153 | positive regulation of interleukin-12 production (GO:0032735) | 2.52884365 |
| 154 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.48848639 |
| 155 | hormone catabolic process (GO:0042447) | 2.48619106 |
| 156 | negative regulation of glycogen metabolic process (GO:0070874) | 2.43487592 |
| 157 | regulation of endopeptidase activity (GO:0052548) | 2.42125148 |
| 158 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.41651720 |
| 159 | response to misfolded protein (GO:0051788) | 2.40087497 |
| 160 | valine metabolic process (GO:0006573) | 2.39234321 |
| 161 | L-serine transport (GO:0015825) | 2.38165018 |
| 162 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.35590920 |
| 163 | alpha-amino acid catabolic process (GO:1901606) | 2.32353146 |
| 164 | lipid catabolic process (GO:0016042) | 2.31294211 |
| 165 | regulation of peptidase activity (GO:0052547) | 2.30174626 |
| 166 | negative regulation of interleukin-6 production (GO:0032715) | 2.29442755 |
| 167 | triglyceride catabolic process (GO:0019433) | 2.28205528 |
| 168 | cellular amino acid catabolic process (GO:0009063) | 2.26254494 |
| 169 | regulation of T cell apoptotic process (GO:0070232) | 2.23814768 |
| 170 | neutral lipid catabolic process (GO:0046461) | 2.20074025 |
| 171 | acylglycerol catabolic process (GO:0046464) | 2.20074025 |
| 172 | positive regulation of sterol transport (GO:0032373) | 2.16711648 |
| 173 | positive regulation of cholesterol transport (GO:0032376) | 2.16711648 |
| 174 | positive regulation of bone resorption (GO:0045780) | 2.15663289 |
| 175 | positive regulation of bone remodeling (GO:0046852) | 2.15663289 |
| 176 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.13658383 |
| 177 | L-phenylalanine catabolic process (GO:0006559) | 2.13658383 |
| 178 | protein-lipid complex remodeling (GO:0034368) | 2.13192852 |
| 179 | macromolecular complex remodeling (GO:0034367) | 2.13192852 |
| 180 | plasma lipoprotein particle remodeling (GO:0034369) | 2.13192852 |
| 181 | regulation of interleukin-10 production (GO:0032653) | 2.09016588 |
| 182 | serine transport (GO:0032329) | 2.08259169 |
| 183 | myelin maintenance (GO:0043217) | 2.08230728 |
| 184 | COPI coating of Golgi vesicle (GO:0048205) | 2.07679662 |
| 185 | Golgi transport vesicle coating (GO:0048200) | 2.07679662 |
| 186 | cellular modified amino acid catabolic process (GO:0042219) | 2.07111048 |
| 187 | regulation of reproductive process (GO:2000241) | 2.06253149 |
| 188 | ethanol oxidation (GO:0006069) | 2.04831371 |
| 189 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.04533774 |
| 190 | production of molecular mediator involved in inflammatory response (GO:0002532) | 14.1783662 |
| 191 | regulation of T cell tolerance induction (GO:0002664) | 14.1420440 |
| 192 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 14.0920869 |
| 193 | positive regulation of tolerance induction (GO:0002645) | 12.1443604 |
| 194 | negative regulation of cAMP-mediated signaling (GO:0043951) | 11.3436934 |
| 195 | sperm capacitation (GO:0048240) | 11.1271985 |
| 196 | sphingosine metabolic process (GO:0006670) | 10.9136465 |
| 197 | regulation of tolerance induction (GO:0002643) | 10.5664998 |
| 198 | kynurenine metabolic process (GO:0070189) | 10.3883388 |
| 199 | opioid receptor signaling pathway (GO:0038003) | 10.3676135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.67635779 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.01504677 |
| 3 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.90894500 |
| 4 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.65696950 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.46406546 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.27959696 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.08241501 |
| 8 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 3.05856102 |
| 9 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.05856102 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.04680501 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.91125382 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.71529716 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.66330705 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.61265606 |
| 15 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.55120818 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.54282404 |
| 17 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51357349 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.42774304 |
| 19 | RXR_22108803_ChIP-Seq_LS180_Human | 2.42081210 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40210675 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.38383359 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32911488 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24843004 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23816499 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23282082 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.13013252 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09995010 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09530915 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07292488 |
| 30 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.99941448 |
| 31 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.98939899 |
| 32 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.94453379 |
| 33 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.94453379 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93381750 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87537506 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86645317 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84201285 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83528374 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83148135 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83028637 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78523382 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76710575 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74913625 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74118706 |
| 45 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.73954426 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.72689649 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70350766 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69591416 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.67736496 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.67736496 |
| 51 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.64648632 |
| 52 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64492586 |
| 53 | TCF4_23295773_ChIP-Seq_U87_Human | 1.63696644 |
| 54 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.61860592 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57554564 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56363328 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55535683 |
| 58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55361640 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55361640 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.55136854 |
| 61 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.52894445 |
| 62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51899322 |
| 63 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.48193013 |
| 64 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.47935674 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47914752 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47368482 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47303873 |
| 68 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.47155665 |
| 69 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.44235952 |
| 70 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.41127571 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.39948011 |
| 72 | * GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.38436859 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38354970 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.37612523 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36764066 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35933872 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33165640 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.33032335 |
| 79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31449277 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30495615 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30268174 |
| 82 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26630553 |
| 83 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.25862879 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25081087 |
| 85 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24579512 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24357619 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24083315 |
| 88 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23806180 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22815526 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22727532 |
| 91 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22563199 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22413141 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22213833 |
| 94 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.21706023 |
| 95 | * STAT1_17558387_ChIP-Seq_HELA_Human | 1.21628015 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19980828 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 1.18656824 |
| 98 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.17715439 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16775519 |
| 100 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.16407531 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15987402 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15665640 |
| 103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15174625 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.14626733 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13606852 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.12954178 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12636181 |
| 108 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12331245 |
| 109 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.11800087 |
| 110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11514743 |
| 111 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.11505331 |
| 112 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11502427 |
| 113 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.11471557 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.10942366 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09731752 |
| 116 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09652002 |
| 117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09641524 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09151823 |
| 119 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.09119926 |
| 120 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09113016 |
| 121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08895707 |
| 122 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08651955 |
| 123 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07972766 |
| 124 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.07386134 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06241990 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06101200 |
| 127 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05832475 |
| 128 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05712641 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05484452 |
| 130 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05283247 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05106187 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04918597 |
| 133 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04490394 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04028925 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03418788 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03328095 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03313773 |
| 138 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03098193 |
| 139 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03076796 |
| 140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02682768 |
| 141 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02678708 |
| 142 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02678080 |
| 143 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02475366 |
| 144 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02379205 |
| 145 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02173702 |
| 146 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01910267 |
| 147 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01752548 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01455568 |
| 149 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.00801039 |
| 150 | AR_19668381_ChIP-Seq_PC3_Human | 1.00659708 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99680331 |
| 152 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.99233287 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99196077 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98683739 |
| 155 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97459057 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96547963 |
| 157 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.96289124 |
| 158 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95583947 |
| 159 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95506698 |
| 160 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94397829 |
| 161 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93879952 |
| 162 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93419579 |
| 163 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93296420 |
| 164 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92588502 |
| 165 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.92538185 |
| 166 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90542968 |
| 167 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89897153 |
| 168 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89831782 |
| 169 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88196725 |
| 170 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88080229 |
| 171 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.87102823 |
| 172 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86651874 |
| 173 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85557896 |
| 174 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85333782 |
| 175 | P300_27268052_Chip-Seq_Bcells_Human | 0.85288117 |
| 176 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83597422 |
| 177 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.82971938 |
| 178 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82077052 |
| 179 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81042626 |
| 180 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80952336 |
| 181 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80874752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.78839831 |
| 2 | MP0009278_abnormal_bone_marrow | 5.32484309 |
| 3 | MP0003195_calcinosis | 5.22418792 |
| 4 | MP0002254_reproductive_system_inflammat | 4.89755741 |
| 5 | MP0004043_abnormal_pH_regulation | 4.61628009 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.17541437 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.98273239 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.83454779 |
| 9 | MP0003045_fibrosis | 3.76838302 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.41751531 |
| 11 | MP0005410_abnormal_fertilization | 3.37872070 |
| 12 | MP0005503_abnormal_tendon_morphology | 3.26070621 |
| 13 | MP0003136_yellow_coat_color | 3.20004888 |
| 14 | MP0003880_abnormal_central_pattern | 3.18757726 |
| 15 | MP0003329_amyloid_beta_deposits | 2.83491122 |
| 16 | MP0000678_abnormal_parathyroid_gland | 2.63891097 |
| 17 | MP0003646_muscle_fatigue | 2.52481619 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.51659146 |
| 19 | MP0003941_abnormal_skin_development | 2.41623083 |
| 20 | MP0009764_decreased_sensitivity_to | 2.35140002 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.22479678 |
| 22 | MP0000681_abnormal_thyroid_gland | 2.11214981 |
| 23 | MP0000003_abnormal_adipose_tissue | 2.09842435 |
| 24 | MP0005360_urolithiasis | 2.09085070 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.06419116 |
| 26 | MP0000604_amyloidosis | 1.97903756 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.96309725 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.94410084 |
| 29 | MP0005171_absent_coat_pigmentation | 1.93556624 |
| 30 | MP0002168_other_aberrant_phenotype | 1.92151734 |
| 31 | MP0001664_abnormal_digestion | 1.80788991 |
| 32 | MP0005365_abnormal_bile_salt | 1.80301206 |
| 33 | MP0009046_muscle_twitch | 1.70462186 |
| 34 | MP0000749_muscle_degeneration | 1.68718420 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.68680748 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.68680748 |
| 37 | MP0004885_abnormal_endolymph | 1.68305283 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.67289231 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.64047745 |
| 40 | MP0001765_abnormal_ion_homeostasis | 1.63680213 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.61247179 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.56881136 |
| 43 | MP0004130_abnormal_muscle_cell | 1.55692128 |
| 44 | MP0009745_abnormal_behavioral_response | 1.55269313 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.54654285 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.53700070 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.53435603 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.53233426 |
| 49 | MP0003950_abnormal_plasma_membrane | 1.52622874 |
| 50 | MP0004147_increased_porphyrin_level | 1.50682173 |
| 51 | MP0001853_heart_inflammation | 1.44060042 |
| 52 | MP0004270_analgesia | 1.43212934 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.42760147 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.42316880 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.41416648 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.37983793 |
| 57 | MP0000534_abnormal_ureter_morphology | 1.33707498 |
| 58 | MP0004859_abnormal_synaptic_plasticity | 1.33403998 |
| 59 | MP0002249_abnormal_larynx_morphology | 1.32686741 |
| 60 | MP0003690_abnormal_glial_cell | 1.32183660 |
| 61 | MP0004858_abnormal_nervous_system | 1.25772238 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.25313330 |
| 63 | MP0005275_abnormal_skin_tensile | 1.24999552 |
| 64 | MP0005332_abnormal_amino_acid | 1.23493819 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.20954098 |
| 66 | MP0003638_abnormal_response/metabolism_ | 1.20718830 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.18572841 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 1.17527921 |
| 69 | MP0001756_abnormal_urination | 1.15036551 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14539368 |
| 71 | MP0005083_abnormal_biliary_tract | 1.13454506 |
| 72 | MP0000537_abnormal_urethra_morphology | 1.12340431 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.12320343 |
| 74 | MP0002089_abnormal_postnatal_growth/wei | 1.09273523 |
| 75 | MP0002796_impaired_skin_barrier | 1.08469319 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 1.08186400 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.07521432 |
| 78 | MP0003632_abnormal_nervous_system | 1.06772987 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.05226273 |
| 80 | MP0002896_abnormal_bone_mineralization | 1.04781938 |
| 81 | MP0002009_preneoplasia | 1.02003638 |
| 82 | MP0005666_abnormal_adipose_tissue | 1.01256258 |
| 83 | MP0002160_abnormal_reproductive_system | 0.97594853 |
| 84 | MP0003252_abnormal_bile_duct | 0.96774284 |
| 85 | MP0003879_abnormal_hair_cell | 0.96654943 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.95697070 |
| 87 | MP0003698_abnormal_male_reproductive | 0.94610317 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.93823115 |
| 89 | MP0000747_muscle_weakness | 0.93618040 |
| 90 | MP0002733_abnormal_thermal_nociception | 0.93565668 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.92919587 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.92519961 |
| 93 | MP0003075_altered_response_to | 0.90669401 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89882378 |
| 95 | MP0005195_abnormal_posterior_eye | 0.89797513 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.86828917 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.86758367 |
| 98 | MP0000920_abnormal_myelination | 0.86752699 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.86744575 |
| 100 | MP0002572_abnormal_emotion/affect_behav | 0.82928225 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.82632694 |
| 102 | MP0002229_neurodegeneration | 0.82171904 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.81237656 |
| 104 | MP0005623_abnormal_meninges_morphology | 0.81226484 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.80922150 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80367100 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.80122951 |
| 108 | MP0002933_joint_inflammation | 0.79905402 |
| 109 | MP0003631_nervous_system_phenotype | 0.79852025 |
| 110 | MP0005389_reproductive_system_phenotype | 0.78407268 |
| 111 | MP0002064_seizures | 0.77992417 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.76740405 |
| 113 | MP0005670_abnormal_white_adipose | 0.75985462 |
| 114 | MP0000609_abnormal_liver_physiology | 0.75915211 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.74926161 |
| 116 | MP0001270_distended_abdomen | 0.74885254 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.74821472 |
| 118 | MP0008874_decreased_physiological_sensi | 0.74274395 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.73362778 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.73123664 |
| 121 | MP0003787_abnormal_imprinting | 0.73117670 |
| 122 | MP0010678_abnormal_skin_adnexa | 0.72915416 |
| 123 | MP0003635_abnormal_synaptic_transmissio | 0.72564979 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.71818497 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.71607865 |
| 126 | MP0002971_abnormal_brown_adipose | 0.69144793 |
| 127 | MP0003633_abnormal_nervous_system | 0.68945176 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.65807594 |
| 129 | MP0000778_abnormal_nervous_system | 0.65495852 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.64958819 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.64752480 |
| 132 | MP0002735_abnormal_chemical_nociception | 0.63601507 |
| 133 | MP0005395_other_phenotype | 0.62699018 |
| 134 | MP0002693_abnormal_pancreas_physiology | 0.62006041 |
| 135 | MP0005535_abnormal_body_temperature | 0.61547713 |
| 136 | MP0008775_abnormal_heart_ventricle | 0.61396011 |
| 137 | MP0000249_abnormal_blood_vessel | 0.61170037 |
| 138 | MP0005334_abnormal_fat_pad | 0.61148143 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.60969383 |
| 140 | MP0008872_abnormal_physiological_respon | 0.59963385 |
| 141 | MP0004272_abnormal_basement_membrane | 0.59419885 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.59168313 |
| 143 | MP0002272_abnormal_nervous_system | 0.59023990 |
| 144 | MP0003634_abnormal_glial_cell | 0.58236203 |
| 145 | MP0004742_abnormal_vestibular_system | 0.57241271 |
| 146 | MP0002295_abnormal_pulmonary_circulatio | 0.56553061 |
| 147 | MP0003959_abnormal_lean_body | 0.56505243 |
| 148 | MP0002138_abnormal_hepatobiliary_system | 0.55646034 |
| 149 | MP0001486_abnormal_startle_reflex | 0.55584850 |
| 150 | MP0000462_abnormal_digestive_system | 0.55581996 |
| 151 | MP0002095_abnormal_skin_pigmentation | 0.55489162 |
| 152 | MP0001666_abnormal_nutrient_absorption | 0.55286460 |
| 153 | MP0001986_abnormal_taste_sensitivity | 0.55120268 |
| 154 | MP0000751_myopathy | 0.53875868 |
| 155 | MP0001970_abnormal_pain_threshold | 0.53702982 |
| 156 | MP0002653_abnormal_ependyma_morphology | 0.52911886 |
| 157 | MP0005377_hearing/vestibular/ear_phenot | 0.52286014 |
| 158 | MP0003878_abnormal_ear_physiology | 0.52286014 |
| 159 | MP0000049_abnormal_middle_ear | 0.50493396 |
| 160 | MP0004142_abnormal_muscle_tone | 0.49947843 |
| 161 | MP0004233_abnormal_muscle_weight | 0.49937813 |
| 162 | MP0002938_white_spotting | 0.49381163 |
| 163 | MP0002166_altered_tumor_susceptibility | 0.49118156 |
| 164 | MP0001881_abnormal_mammary_gland | 0.48952597 |
| 165 | MP0009840_abnormal_foam_cell | 0.48622750 |
| 166 | MP0010771_integument_phenotype | 0.48372341 |
| 167 | MP0002161_abnormal_fertility/fecundity | 0.47722529 |
| 168 | MP0008057_abnormal_DNA_replication | 0.47390192 |
| 169 | MP0004381_abnormal_hair_follicle | 0.47124705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.87262835 |
| 2 | Volvulus (HP:0002580) | 6.68648649 |
| 3 | Intestinal atresia (HP:0011100) | 6.23464304 |
| 4 | Broad alveolar ridges (HP:0000187) | 5.60099047 |
| 5 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.45850136 |
| 6 | Abnormality of the aortic arch (HP:0012303) | 5.39899046 |
| 7 | Myocardial infarction (HP:0001658) | 5.35672753 |
| 8 | Hypophosphatemic rickets (HP:0004912) | 5.24307233 |
| 9 | Facial shape deformation (HP:0011334) | 5.16241506 |
| 10 | Potter facies (HP:0002009) | 5.16241506 |
| 11 | Vascular calcification (HP:0004934) | 4.97519489 |
| 12 | Complement deficiency (HP:0004431) | 4.94941578 |
| 13 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.85098606 |
| 14 | Large for gestational age (HP:0001520) | 4.75611000 |
| 15 | Thickened helices (HP:0000391) | 4.64976128 |
| 16 | Cardiovascular calcification (HP:0011915) | 4.62240854 |
| 17 | Oligodontia (HP:0000677) | 4.56250520 |
| 18 | Choroideremia (HP:0001139) | 4.47790119 |
| 19 | Neurofibrillary tangles (HP:0002185) | 4.36469938 |
| 20 | Amelogenesis imperfecta (HP:0000705) | 4.34802966 |
| 21 | Poor head control (HP:0002421) | 4.22796505 |
| 22 | Mesangial abnormality (HP:0001966) | 4.21032095 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 4.16328337 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 4.08077689 |
| 25 | Tubular atrophy (HP:0000092) | 3.99089188 |
| 26 | Malnutrition (HP:0004395) | 3.78877092 |
| 27 | Dialeptic seizures (HP:0011146) | 3.62359049 |
| 28 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.61537204 |
| 29 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.61537204 |
| 30 | Type II lissencephaly (HP:0007260) | 3.58314573 |
| 31 | Abnormality of complement system (HP:0005339) | 3.56492875 |
| 32 | Focal seizures (HP:0007359) | 3.53026265 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52944229 |
| 34 | Cerebellar dysplasia (HP:0007033) | 3.48312734 |
| 35 | Infantile muscular hypotonia (HP:0008947) | 3.42702821 |
| 36 | Neoplasm of the heart (HP:0100544) | 3.40284889 |
| 37 | Intention tremor (HP:0002080) | 3.27016092 |
| 38 | Abnormality of the ileum (HP:0001549) | 3.26533925 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.22642255 |
| 40 | Rickets (HP:0002748) | 3.22330155 |
| 41 | Abnormality of the fovea (HP:0000493) | 3.17763399 |
| 42 | Agitation (HP:0000713) | 3.16370223 |
| 43 | Large eyes (HP:0001090) | 3.15283210 |
| 44 | Widely patent fontanelles and sutures (HP:0004492) | 3.13278371 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 3.12071224 |
| 46 | Xanthomatosis (HP:0000991) | 3.04729014 |
| 47 | Gastrointestinal atresia (HP:0002589) | 3.03210492 |
| 48 | Choreoathetosis (HP:0001266) | 2.99123267 |
| 49 | Hyperthyroidism (HP:0000836) | 2.96057346 |
| 50 | Tented upper lip vermilion (HP:0010804) | 2.89086549 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.88049199 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.85242624 |
| 53 | Chromsome breakage (HP:0040012) | 2.84588818 |
| 54 | Progressive inability to walk (HP:0002505) | 2.82710606 |
| 55 | Hemiplegia (HP:0002301) | 2.81650535 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.77691577 |
| 57 | Neonatal respiratory distress (HP:0002643) | 2.77233512 |
| 58 | Hypoproteinemia (HP:0003075) | 2.74425128 |
| 59 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.73787389 |
| 60 | Hypoplasia of the brainstem (HP:0002365) | 2.73787389 |
| 61 | Lissencephaly (HP:0001339) | 2.71019204 |
| 62 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.70665856 |
| 63 | Abnormality of macular pigmentation (HP:0008002) | 2.70119664 |
| 64 | Abnormality of the alveolar ridges (HP:0006477) | 2.68942624 |
| 65 | Polar cataract (HP:0010696) | 2.68063555 |
| 66 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.63001491 |
| 67 | Hypopigmentation of the fundus (HP:0007894) | 2.61036652 |
| 68 | Ketoacidosis (HP:0001993) | 2.58918871 |
| 69 | Peripheral hypomyelination (HP:0007182) | 2.57381546 |
| 70 | Pendular nystagmus (HP:0012043) | 2.52514250 |
| 71 | Hyperpituitarism (HP:0010514) | 2.51817273 |
| 72 | Osteomalacia (HP:0002749) | 2.49945330 |
| 73 | Myositis (HP:0100614) | 2.48853801 |
| 74 | Embryonal renal neoplasm (HP:0011794) | 2.48164869 |
| 75 | Broad-based gait (HP:0002136) | 2.47639619 |
| 76 | Optic nerve hypoplasia (HP:0000609) | 2.47363004 |
| 77 | Ketosis (HP:0001946) | 2.40822881 |
| 78 | Ulnar claw (HP:0001178) | 2.38249296 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.35043616 |
| 80 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.34937858 |
| 81 | Gout (HP:0001997) | 2.34521900 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.34285184 |
| 83 | Hyperglycinuria (HP:0003108) | 2.33442819 |
| 84 | Increased corneal curvature (HP:0100692) | 2.33389115 |
| 85 | Keratoconus (HP:0000563) | 2.33389115 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.30824392 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 2.30703700 |
| 88 | Difficulty running (HP:0009046) | 2.30645734 |
| 89 | Skin nodule (HP:0200036) | 2.28965015 |
| 90 | Testicular atrophy (HP:0000029) | 2.28671593 |
| 91 | Abnormal hemoglobin (HP:0011902) | 2.27677964 |
| 92 | Dysdiadochokinesis (HP:0002075) | 2.25849442 |
| 93 | Orchitis (HP:0100796) | 2.25448556 |
| 94 | Acanthosis nigricans (HP:0000956) | 2.24935608 |
| 95 | Severe visual impairment (HP:0001141) | 2.24215405 |
| 96 | Central scotoma (HP:0000603) | 2.23318246 |
| 97 | Pancreatic cysts (HP:0001737) | 2.21118668 |
| 98 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16273581 |
| 99 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.15807215 |
| 100 | Focal segmental glomerulosclerosis (HP:0000097) | 2.15610503 |
| 101 | Hyporeflexia of lower limbs (HP:0002600) | 2.14997874 |
| 102 | Thin bony cortex (HP:0002753) | 2.12918594 |
| 103 | Abnormality of the vitreous humor (HP:0004327) | 2.11860066 |
| 104 | Abnormality of secondary sexual hair (HP:0009888) | 2.11405173 |
| 105 | Abnormality of the axillary hair (HP:0100134) | 2.11405173 |
| 106 | Ectropion (HP:0000656) | 2.11393084 |
| 107 | Goiter (HP:0000853) | 2.09271238 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.07956845 |
| 109 | Hyperphosphatemia (HP:0002905) | 2.07379735 |
| 110 | Gait ataxia (HP:0002066) | 2.06717052 |
| 111 | Impulsivity (HP:0100710) | 2.05548733 |
| 112 | Parakeratosis (HP:0001036) | 2.04148044 |
| 113 | Abnormality of glycine metabolism (HP:0010895) | 2.02740422 |
| 114 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02740422 |
| 115 | Pili torti (HP:0003777) | 2.02325615 |
| 116 | Poor speech (HP:0002465) | 2.02010849 |
| 117 | Hyperparathyroidism (HP:0000843) | 2.01745332 |
| 118 | Spastic diplegia (HP:0001264) | 2.01075732 |
| 119 | Ileus (HP:0002595) | 2.01066282 |
| 120 | Thyroid-stimulating hormone excess (HP:0002925) | 12.9397370 |
| 121 | Epidermoid cyst (HP:0200040) | 1.99344852 |
| 122 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.99055043 |
| 123 | Hepatoblastoma (HP:0002884) | 1.96891190 |
| 124 | Hypoplastic iliac wings (HP:0002866) | 1.96786962 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.96314320 |
| 126 | Myokymia (HP:0002411) | 1.96224218 |
| 127 | Non-midline cleft lip (HP:0100335) | 1.95988272 |
| 128 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95224680 |
| 129 | Hypoplasia of the pons (HP:0012110) | 1.95024331 |
| 130 | Ectopia lentis (HP:0001083) | 1.94220416 |
| 131 | Tubulointerstitial fibrosis (HP:0005576) | 1.93643028 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.93543029 |
| 133 | Hyperlipoproteinemia (HP:0010980) | 1.93033211 |
| 134 | Right ventricular cardiomyopathy (HP:0011663) | 1.91916352 |
| 135 | Attenuation of retinal blood vessels (HP:0007843) | 1.91387526 |
| 136 | Muscle fiber splitting (HP:0003555) | 1.90752625 |
| 137 | Scotoma (HP:0000575) | 1.90521522 |
| 138 | Hyperammonemia (HP:0001987) | 1.87716943 |
| 139 | Restlessness (HP:0000711) | 1.86428989 |
| 140 | Long nose (HP:0003189) | 1.86046835 |
| 141 | Inability to walk (HP:0002540) | 1.85475268 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 1.85258900 |
| 143 | Hypophosphatemia (HP:0002148) | 1.85068646 |
| 144 | Glomerulosclerosis (HP:0000096) | 1.84460658 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84191932 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84191932 |
| 147 | Progressive neurologic deterioration (HP:0002344) | 1.84041366 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.83056743 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.83056743 |
| 150 | Hamartoma (HP:0010566) | 1.82477433 |
| 151 | Hypohidrosis (HP:0000966) | 1.80482588 |
| 152 | Nonprogressive disorder (HP:0003680) | 1.80264774 |
| 153 | Atonic seizures (HP:0010819) | 1.79705496 |
| 154 | Wide cranial sutures (HP:0010537) | 1.78681090 |
| 155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78259328 |
| 156 | Pancreatic fibrosis (HP:0100732) | 1.77074081 |
| 157 | Status epilepticus (HP:0002133) | 1.75888325 |
| 158 | High anterior hairline (HP:0009890) | 1.75562090 |
| 159 | Gangrene (HP:0100758) | 1.74164640 |
| 160 | Oligomenorrhea (HP:0000876) | 1.74014734 |
| 161 | Lack of skin elasticity (HP:0100679) | 1.73827514 |
| 162 | Amyloidosis (HP:0011034) | 1.73653948 |
| 163 | Muscular dystrophy (HP:0003560) | 1.72365065 |
| 164 | Peritonitis (HP:0002586) | 1.71806963 |
| 165 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71512107 |
| 166 | Action tremor (HP:0002345) | 1.71479241 |
| 167 | Striae distensae (HP:0001065) | 1.71393944 |
| 168 | Prominent nose (HP:0000448) | 1.71293547 |
| 169 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70944399 |
| 170 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70944399 |
| 171 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70944399 |
| 172 | Increased connective tissue (HP:0009025) | 1.70833959 |
| 173 | Difficulty walking (HP:0002355) | 1.70726224 |
| 174 | Aplastic anemia (HP:0001915) | 1.70709877 |
| 175 | True hermaphroditism (HP:0010459) | 1.69678439 |
| 176 | Facial diplegia (HP:0001349) | 1.69314226 |
| 177 | Psychosis (HP:0000709) | 1.67438491 |
| 178 | Autoimmune hemolytic anemia (HP:0001890) | 1.67434913 |
| 179 | Hypoalphalipoproteinemia (HP:0003233) | 1.67309630 |
| 180 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66609175 |
| 181 | Loss of speech (HP:0002371) | 1.66539917 |
| 182 | Hyperglycinemia (HP:0002154) | 1.66234633 |
| 183 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65805455 |
| 184 | Abnormality of the renal cortex (HP:0011035) | 1.65654137 |
| 185 | Abnormality of the periventricular white matter (HP:0002518) | 1.64947941 |
| 186 | Gastrointestinal dysmotility (HP:0002579) | 1.64537405 |
| 187 | Increased CSF protein (HP:0002922) | 1.64517619 |
| 188 | Abnormality of macrophages (HP:0004311) | 1.63581121 |
| 189 | Late onset (HP:0003584) | 1.63476322 |
| 190 | Calf muscle hypertrophy (HP:0008981) | 1.62824793 |
| 191 | Pigmentary retinal degeneration (HP:0001146) | 1.62507133 |
| 192 | Subcapsular cataract (HP:0000523) | 1.61234038 |
| 193 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.60535218 |
| 194 | Gonadotropin excess (HP:0000837) | 1.59920594 |
| 195 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59843525 |
| 196 | Mucopolysacchariduria (HP:0008155) | 1.59843525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 9.30330356 |
| 2 | PINK1 | 3.88320778 |
| 3 | MST4 | 3.77404773 |
| 4 | STK38L | 3.48286368 |
| 5 | ERN1 | 3.34179439 |
| 6 | LMTK2 | 3.20291356 |
| 7 | IRAK3 | 2.88321155 |
| 8 | EPHB1 | 2.80123798 |
| 9 | SIK1 | 2.65250561 |
| 10 | ADRBK1 | 2.61412330 |
| 11 | IRAK1 | 2.37315010 |
| 12 | LRRK2 | 2.37274076 |
| 13 | ACVR1B | 2.36260998 |
| 14 | PKN2 | 2.33891315 |
| 15 | FGFR2 | 2.24570717 |
| 16 | TRIB3 | 2.22425888 |
| 17 | FER | 2.15346084 |
| 18 | TAOK3 | 2.13715346 |
| 19 | PDGFRA | 2.13268128 |
| 20 | PNCK | 2.09700058 |
| 21 | FGFR4 | 1.96833405 |
| 22 | WNK4 | 1.95259426 |
| 23 | MUSK | 1.93458465 |
| 24 | STK39 | 1.84304194 |
| 25 | PRKD3 | 1.74141408 |
| 26 | BMPR1B | 1.65775719 |
| 27 | ZAK | 1.57737641 |
| 28 | TGFBR1 | 1.50857460 |
| 29 | MAP3K2 | 1.50505924 |
| 30 | DYRK3 | 1.47479325 |
| 31 | TNK2 | 1.46980574 |
| 32 | PTK6 | 1.42744699 |
| 33 | PRKCE | 1.40064857 |
| 34 | RET | 1.36412530 |
| 35 | TTN | 1.33919758 |
| 36 | TYRO3 | 1.31859410 |
| 37 | MYLK | 1.31852871 |
| 38 | STK3 | 1.30166467 |
| 39 | MAP2K2 | 1.29304016 |
| 40 | EPHA2 | 1.26533815 |
| 41 | NTRK3 | 1.25117485 |
| 42 | RIPK4 | 1.23972107 |
| 43 | PTK2B | 1.22775409 |
| 44 | STK10 | 1.20698672 |
| 45 | PTK2 | 1.19715072 |
| 46 | PAK3 | 1.18379050 |
| 47 | INSR | 1.16163540 |
| 48 | NTRK1 | 1.15568001 |
| 49 | MELK | 1.11888240 |
| 50 | MAP2K4 | 1.11565071 |
| 51 | CDK19 | 1.02591146 |
| 52 | SCYL2 | 1.02556531 |
| 53 | PRKCH | 1.00262134 |
| 54 | NEK2 | 0.98825913 |
| 55 | PAK6 | 0.98088901 |
| 56 | FRK | 0.98032336 |
| 57 | GRK7 | 0.95785813 |
| 58 | TESK1 | 0.95506663 |
| 59 | CLK1 | 0.95317296 |
| 60 | GRK1 | 0.93647134 |
| 61 | FGFR3 | 0.93443856 |
| 62 | KSR2 | 0.91441538 |
| 63 | MAP3K7 | 0.91000111 |
| 64 | BCKDK | 0.89743783 |
| 65 | NEK9 | 0.89495883 |
| 66 | MAPK11 | 0.88878032 |
| 67 | EPHB2 | 0.86344273 |
| 68 | MAP3K12 | 0.85761563 |
| 69 | DMPK | 0.84540560 |
| 70 | PAK2 | 0.82340746 |
| 71 | CDK5 | 0.79553142 |
| 72 | ALK | 0.77017456 |
| 73 | PLK2 | 0.76738141 |
| 74 | CAMK1G | 0.76352122 |
| 75 | GSK3A | 0.75037658 |
| 76 | PAK4 | 0.74944938 |
| 77 | PRKCI | 0.74013319 |
| 78 | PRKG2 | 0.73743314 |
| 79 | LATS2 | 0.72966158 |
| 80 | MAPKAPK5 | 0.72904774 |
| 81 | CAMK2A | 0.72523638 |
| 82 | AKT3 | 0.72502836 |
| 83 | PHKG1 | 0.71268442 |
| 84 | PHKG2 | 0.71268442 |
| 85 | WNK1 | 0.70834492 |
| 86 | PRKCG | 0.70253128 |
| 87 | NTRK2 | 0.70207033 |
| 88 | MAP3K6 | 0.69256477 |
| 89 | DAPK2 | 0.67115001 |
| 90 | ICK | 0.66167287 |
| 91 | EPHA4 | 0.66021725 |
| 92 | JAK2 | 0.65782029 |
| 93 | MAP2K1 | 0.65161175 |
| 94 | DDR2 | 0.64907771 |
| 95 | SIK2 | 0.63975900 |
| 96 | SRC | 0.63974156 |
| 97 | PDK3 | 0.62259813 |
| 98 | PDK4 | 0.62259813 |
| 99 | FYN | 0.60339766 |
| 100 | PDGFRB | 0.60104882 |
| 101 | RIPK1 | 0.59744380 |
| 102 | MAP3K13 | 0.59023929 |
| 103 | FGFR1 | 0.57384577 |
| 104 | ROCK2 | 0.57279490 |
| 105 | UHMK1 | 0.56623106 |
| 106 | PRKACG | 0.55778278 |
| 107 | CAMK1D | 0.53621588 |
| 108 | PRKD1 | 0.53524581 |
| 109 | MINK1 | 0.53258717 |
| 110 | CSNK1E | 0.53049509 |
| 111 | PRKCZ | 0.53023247 |
| 112 | CSNK1A1L | 0.52370657 |
| 113 | FLT3 | 0.51888527 |
| 114 | MET | 0.51503316 |
| 115 | STK38 | 0.51228945 |
| 116 | EGFR | 0.50773573 |
| 117 | GRK5 | 0.49786199 |
| 118 | CDK6 | 0.49080925 |
| 119 | ERBB2 | 0.47713942 |
| 120 | OXSR1 | 0.46705318 |
| 121 | LATS1 | 0.46635626 |
| 122 | EEF2K | 0.46203569 |
| 123 | FES | 0.45574587 |
| 124 | INSRR | 0.43417140 |
| 125 | MOS | 0.43124254 |
| 126 | PRKCQ | 0.42698747 |
| 127 | JAK1 | 0.42507483 |
| 128 | WEE1 | 0.42179710 |
| 129 | BMX | 0.41478366 |
| 130 | PIK3CG | 0.41339941 |
| 131 | CSK | 0.41151186 |
| 132 | NLK | 0.40458601 |
| 133 | PDPK1 | 0.39412285 |
| 134 | CASK | 0.35881931 |
| 135 | TIE1 | 0.34951306 |
| 136 | SGK1 | 0.33914436 |
| 137 | TAF1 | 0.33026684 |
| 138 | PRKCB | 0.32655046 |
| 139 | TGFBR2 | 0.32134237 |
| 140 | BRSK1 | 0.30473933 |
| 141 | PRKAA2 | 0.29719992 |
| 142 | MAPK1 | 0.29566431 |
| 143 | CAMK1 | 0.29439981 |
| 144 | MAPK3 | 0.29319462 |
| 145 | WNK3 | 0.28810021 |
| 146 | AKT1 | 0.25943444 |
| 147 | MKNK1 | 0.25785100 |
| 148 | PRKACA | 0.25265515 |
| 149 | RPS6KA3 | 0.24919711 |
| 150 | ABL1 | 0.24617331 |
| 151 | MST1R | 0.23173324 |
| 152 | MKNK2 | 0.22350994 |
| 153 | MAP4K2 | 0.22316046 |
| 154 | BRAF | 0.22058756 |
| 155 | PRKCA | 0.21818818 |
| 156 | MARK1 | 0.21454025 |
| 157 | EIF2AK3 | 0.20993110 |
| 158 | CAMK4 | 0.19051775 |
| 159 | MAPK13 | 0.18563072 |
| 160 | MAPK15 | 0.18094699 |
| 161 | CSNK1A1 | 0.16864769 |
| 162 | DYRK1A | 0.15221240 |
| 163 | TSSK6 | 0.14519488 |
| 164 | MARK3 | 0.14251894 |
| 165 | GSK3B | 0.12905096 |
| 166 | CSNK1G2 | 0.12842227 |
| 167 | TEC | 0.10196169 |
| 168 | TXK | 0.09624695 |
| 169 | CSNK2A2 | 0.09090836 |
| 170 | PRKACB | 0.08932778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.08001070 |
| 2 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 4.23465433 |
| 3 | Glutathione metabolism_Homo sapiens_hsa00480 | 4.23009936 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 4.00177872 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.77861977 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.45694229 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.44360373 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.42814055 |
| 9 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.31356041 |
| 10 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.26350954 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.21837854 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.87157460 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66371829 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.53347739 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.45477107 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.28008513 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15110706 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12940561 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06844224 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02203625 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96385400 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.88313936 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79771957 |
| 24 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.72291484 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70761365 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67579756 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67310169 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59137077 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54721204 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51436094 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49327598 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47596357 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.38703330 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.38571675 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.38305900 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20754645 |
| 37 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.17765313 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17090773 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14889625 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11969409 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11474718 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11276277 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.10380587 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09101090 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05827458 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02645851 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.99791943 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99464910 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98608619 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93832214 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.93563409 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93143212 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93084446 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92865926 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91572678 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89057474 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88712188 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86938059 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86348238 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86256464 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84314432 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83047192 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82957290 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79918603 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77230028 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74385809 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72743881 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72738698 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72265060 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71572554 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71326991 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71115510 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70391611 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69679954 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.67801943 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.65952977 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64330122 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63702098 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62727953 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62692634 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61878106 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61850605 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61703132 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61701149 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61047694 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60959811 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60507623 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59415890 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58982339 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58208361 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.56880138 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54345525 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53628109 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52983156 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51850033 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50895663 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50146097 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49418240 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49330924 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48481989 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48010313 |
| 102 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47808058 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47360973 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46668594 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46172737 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45891095 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45309748 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45095021 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45007484 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44803733 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.44690176 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.43498687 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41671043 |
| 114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41620621 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41515110 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39967675 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.39885183 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39293385 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38867170 |
| 120 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37711095 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37274953 |
| 122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36684320 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36409507 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36374759 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35534390 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.35441473 |
| 127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35027205 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33176219 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32996629 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32097345 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31218798 |
| 132 | Homologous recombination_Homo sapiens_hsa03440 | 0.30747064 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30457875 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30242204 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30123364 |
| 136 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30021782 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29936868 |
| 138 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29697957 |
| 139 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29521544 |
| 140 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28743351 |
| 141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28605713 |
| 142 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28450334 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.28295547 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.26027101 |
| 145 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25364690 |
| 146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24498622 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24127190 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.24046144 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20576481 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18918287 |
| 151 | Legionellosis_Homo sapiens_hsa05134 | 0.18375091 |
| 152 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16731152 |
| 153 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.13048397 |
| 154 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12914557 |

